Innovative approaches in the treatment and support of patients with acute myelogenous leukemia.
Department of Hematology and BMT, Rambam Medical Center and Technion, Israel Institute of Technology, Haifa 31096, Israel. rowe@jimmy.harvard.edu
Jacob M
JM
Rowe
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D033581:Stem Cell Transplantation; D016896:Treatment Outcome
D000970:Antineoplastic Agents